D. Mullins

发表

Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology

M. Netea, Salim Dhanji, Stephanie W. Y. Wong, 2020, Scientific Reports.

The right microbial stimulus can direct innate immune effector cells to specific organ sites to clear pathology

M. Netea, Salim Dhanji, Stephanie W. Y. Wong, 2019, bioRxiv.

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease

Yina H. Huang, M. Turk, W. Croteau, 2015, Cancer Immunology Research.

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

V. Engelhard, C. Slingluff, W. Grosh, 2006, Advances in immunology.

Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma

C. Brinckerhoff, W. Croteau, Molly H. Jenkins, 2013, Journal of cellular physiology.

Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma

M. Burdick, R. Strieter, C. Slingluff, 2010, Journal of immunotherapy.

Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

V. Engelhard, Teresa A. Colella, T. Bullock, 2002, Immunological reviews.

Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung

S. Fiering, R. A. Cramer, G. Ostroff, 2018, Cancer Immunology, Immunotherapy.

Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.

D. Mullins, C. J. Burger, K. D. Elgert, 1999, Journal of immunology.

This information is current as HLA-A*0201-Transgenic Mice Control of Melanoma Outgrowth in Tyrosinase and Glycoprotein 100 Enable HLA-A*0201-Restricted Epitopes of Immune Responses to the

V. Engelhard, Teresa A. Colella, T. Bullock, 2013 .

Class I-Transgenic Mice T Cells for Melanoma Immunotherapy in + Effectiveness of Adoptively Transferred CD 8 Manipulation of Avidity to Improve and

V. Engelhard, Teresa A. Colella, T. Bullock, 2001 .

Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice1

V. Engelhard, Teresa A. Colella, T. Bullock, 2001, The Journal of Immunology.

Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen

V. Engelhard, R. Pierce, C. J. Luckey, 2000, The Journal of experimental medicine.

Paclitaxel-induced macrophage activities in the tumor-bearing host: immunologic implications and therapeutic applications

D. Mullins, 1998 .

Differential expression and tumor necrosis factor‐mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas

J. Oliver, D. Mullins, M. P. Alexander, 2013, Pigment cell & melanoma research.

Potential candidate genomic biomarkers of drug induced vascular injury in the rat.

M. Magid-Slav, K. Tatsuoka, Heath C. Thomas, 2011, Toxicology and applied pharmacology.

This information is current as Responses in Peripheral Lymph Nodes Cells and Naive T Cells Restricts Immune Limited Infiltration of Exogenous Dendritic

V. Engelhard, D. Mullins, 2006 .

Limited Infiltration of Exogenous Dendritic Cells and Naive T Cells Restricts Immune Responses in Peripheral Lymph Nodes1

V. Engelhard, D. Mullins, 2006, The Journal of Immunology.

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

S. Sutcliffe, B. Bressler, D. Mullins, 2015, Gastroenterology research and practice.

The Protein Tyrosine Phosphatase SHP-1 Modulates the Suppressive Activity of Regulatory T Cells

U. Lorenz, D. Mullins, T. Iype, 2010, The Journal of Immunology.

Antigen Density Presented By Dendritic Cells In Vivo Differentially Affects the Number and Avidity of Primary, Memory, and Recall CD8+ T Cells 1

V. Engelhard, T. Bullock, D. Mullins, 2003, The Journal of Immunology.

Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge

P. Lizotte, S. Fiering, M. Bosenberg, 2013, The Journal of Immunology.

This information is current as against Rechallenge Protects Toxoplasma gondii of Attenuated InjectionB 16 F 10 Melanoma by Intratumoral Immune-Mediated Regression of Established

P. Lizotte, S. Fiering, M. Bosenberg, 2012 .

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases

F. Marincola, R. Clark, N. Wages, 2016, Cancer Immunology, Immunotherapy.

Peptide Vaccination in Montanide Adjuvant Induces and GM-CSF Increases CXCR3 and Cutaneous Lymphocyte Antigen Expression by Tumor Antigen–Specific CD8 T Cells

C. Slingluff, D. Mullins, E. Clancy-Thompson, 2013, Cancer Immunology Research.

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

F. Marincola, N. Wages, C. Slingluff, 2016, Cancer Immunology, Immunotherapy.

This information is current as Melanoma Cell Responses in a Long-Term Survivor of Sequential Immune Escape and Shifting of T Ferrone

V. Engelhard, C. Slingluff, S. Ferrone, 2005 .

Defective Human Leukocyte Antigen Class I-associated Antigen Presentation Caused by a Novel β2-Microglobulin Loss-of-function in Melanoma Cells*

C. Slingluff, S. Ferrone, G. Yamshchikov, 2006, Journal of Biological Chemistry.

The IL-20RB receptor and the IL-20 signaling pathway in regulating host defense in oral mucosal candidiasis

P. Sundstrom, D. Mullins, A. Y. Kim, 2022, Frontiers in Cellular and Infection Microbiology.

Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production.

D. Mullins, C. J. Burger, K. D. Elgert, 1997, Immunopharmacology.

Taxol-mediated changes in fibrosarcoma-induced immune cell function: Modulation of antitumor activities

D. Mullins, T. M. Walker, C. J. Burger, 1997, Cancer Immunology, Immunotherapy.

Through Production in Tumor-Bearing Hosts Paclitaxel Enhances Macrophage IL-12

D. Mullins, C. J. Burger, K. D. Elgert, 1999 .

Nitric Oxide ThroughProduction in Tumor-Bearing Hosts Paclitaxel Enhances Macrophage IL-12

D. Mullins, C. J. Burger, K. D. Elgert, 1999 .

Tumor-Derived Cytokines Dysregulate Macrophage Interferon-γ Responsiveness and Interferon Regulatory Factor-8 Expression

D. Mullins, K. D. Elgert, R. S. Martins, 2003, Experimental biology and medicine.

Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.

M. Koci, D. Mullins, C. J. Burger, 1998, Immunopharmacology and immunotoxicology.

Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.

D. Mullins, C. J. Burger, K. D. Elgert, 1998, International journal of immunopharmacology.

Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032

J. Fisher, M. Ernstoff, C. Brinckerhoff, 2014, Pigment cell & melanoma research.

Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses

N. Hacohen, L. Garraway, G. Freeman, 2021, Science Translational Medicine.

A male genital tract-specific carbohydrate epitope on human CD52: implications for immunocontraception.

C J Flickinger, J C Herr, V. Engelhard, 2002, Tissue antigens.

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy

S. Lam, S. Sutcliffe, Salim Dhanji, 2017, Oncoimmunology.

LNK suppresses interferon signaling in melanoma

J. Wilmott, R. Scolyer, Henry Yang, 2019, Nature Communications.

CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases

D. Mullins, E. Clancy-Thompson, Kiah L Butler, 2017, Scientific Reports.

Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.

Chao Cheng, Chao Cheng, S. Fiering, 2017, Cancer research.

Adaptive immunity programmes in breast cancer

Chao Cheng, S. Fiering, F. Varn, 2017, Immunology.

Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control

V. Engelhard, yang-xin fu, Rebecca M. Ream, 2003, The Journal of experimental medicine.

Tumor‐induced immune dysfunction: the macrophage connection

D. Mullins, K. D. Elgert, D. Alleva, 1998, Journal of leukocyte biology.

Species-specific Inflammatory Responses as a Primary Component for the Development of Glomerular Lesions in Mice and Monkeys Following Chronic Administration of a Second-generation Antisense Oligonucleotide

R. Mirabile, J. Ridings, Victoria Derr, 2014, Toxicologic pathology.

A TLR7 agonist strengthens T and NK cell function during BRAF‐targeted therapy in a preclinical melanoma model

G. Cappellano, C. Brinckerhoff, L. Bellmann, 2019, International journal of cancer.

Tumor cell‐derived TGF‐β and IL‐10 dysregulate paclitaxel‐induced macrophage activation

D. Mullins, C. J. Burger, K. D. Elgert, 2001, Journal of leukocyte biology.

The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells

C. Brinckerhoff, W. Croteau, Molly H. Jenkins, 2015, Matrix biology : journal of the International Society for Matrix Biology.

Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice1

David W. Mullins, V. Engelhard, Timothy N. J. Bullock, 2001, The Journal of Immunology.

Adaptive immunity programs in breast cancer Adaptive immunity in breast cancer

Chao Cheng, S. Fiering, F. Varn, 2016 .

Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles

Chao Cheng, David W. Mullins, Frederick S. Varn, 2016, Nature Communications.

CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity

C. Brinckerhoff, Molly H. Jenkins, D. Mullins, 2015, PloS one.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

J. Fisher, M. Ernstoff, C. Fadul, 2016, Melanoma research.

BRAF Inhibition Alleviates Immune Suppression in Murine Autochthonous Melanoma

M. Ernstoff, M. Bosenberg, C. Brinckerhoff, 2014, Cancer Immunology Research.

Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma 1

V. Engelhard, C. Slingluff, S. Ferrone, 2005, The Journal of Immunology.

CXC Chemokine Receptor 3 Expression by Activated CD8+ T cells Is Associated with Survival in Melanoma Patients with Stage III Disease

W. Knaus, C. Slingluff, Jianfeng Shu, 2004, Cancer Research.

Extracellular Hepatitis C Virus Core Protein Activates STAT3 in Human Monocytes/Macrophages/Dendritic Cells via an IL-6 Autocrine Pathway*

Virginia Nguyen, A. Tosello-Trampont, D. Mullins, 2011, The Journal of Biological Chemistry.